NCT02297607

Brief Summary

Patients undergoing an esophagectomy will be randomized to receive either (1) routine post-operative tube feeding for 1 month post-operative or (2) usual practice, which is tube feeding to continue in the hospital until the patient is taking adequate nutrition by mouth at POD#8, or upon discharge. Specific Aim 1 is to determine the occurrence of common complications and readmissions post-operatively between the two patient groups. The investigators hypothesize that routine use of tube feeding may reduce the occurrence of post-operative complications. Specific Aim 2 is to determine if routine dietary supplementation with enteral tube affects recovery and QOL after esophagectomy. The investigators hypothesize that routine post-operative supplementation will enhance patients recovery and QOL. For esophagectomy specifically, there is very limited literature evaluating the complication rate and QOL associated with the length of post-operative tube feeding and adequate nutritional requirements. Small randomized studies have not shown a benefit to routine tube feeding, although the numbers were very small, ranging from 12-70 per group. The investigators will randomize 200 patients for the purpose of this study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2014

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 21, 2014

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

August 27, 2020

Status Verified

August 1, 2020

Enrollment Period

4.3 years

First QC Date

September 11, 2014

Last Update Submit

August 18, 2020

Conditions

Keywords

Esophageal CancerEsophagectomy

Outcome Measures

Primary Outcomes (1)

  • Quality of Life after surgery

    Quality of Life will be assessed using the EORTC QLQ-30 Survey Instrument. Post-operative QOL assessment will be compared to baseline (prior to surgery) QOL assessment.

    6-months post-operatively

Secondary Outcomes (1)

  • Jejunostomy tube-specific complications

    2-weeks, 1-month, 3-months and 6-months post-operatively

Other Outcomes (3)

  • Other post-operative complications

    30-days post-operative

  • Costs

    6-months post-operative

  • Length of hospital stay

    2-weeks post-operative

Study Arms (2)

Tube Feeding

EXPERIMENTAL

Study subjects will continue to receive tube feedings (for at least 50% of caloric need) for 1-month post-operatively.

Dietary Supplement: Tube Feeding

Standard of Care

NO INTERVENTION

Tube feeding to continue in the hospital until the patient is taking adequate nutrition by mouth at post-op day #8, or upon discharge,

Interventions

Tube FeedingDIETARY_SUPPLEMENT
Also known as: Boost, Ensure, Nutren 1.0, Osmolite, Replete
Tube Feeding

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing an elective esophagectomy
  • Jejunal feeding tube placed at the time of surgery

You may not qualify if:

  • Emergent esophagectomy procedure
  • Inability to provide informed consent or to complete testing or data collection
  • Unwillingness to be randomized
  • Tube feeding dependent on discharge

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan Health System

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Esophageal Neoplasms

Interventions

Enteral NutritionOsmolite

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases

Intervention Hierarchy (Ancestors)

Feeding MethodsTherapeuticsNutritional SupportNutrition Therapy

Study Officials

  • Philip W Carrott, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Thoracic Surgery, Medical School

Study Record Dates

First Submitted

September 11, 2014

First Posted

November 21, 2014

Study Start

November 1, 2014

Primary Completion

March 1, 2019

Study Completion

May 1, 2019

Last Updated

August 27, 2020

Record last verified: 2020-08

Locations